Gene therapy of chondrosarcoma using retrovirus vectors encoding the herpes simplex virus thymidine kinase gene

被引：0
|
作者：
Seto, M
Wakabayashi, H
Yamazaki, T
Sonoda, J
Shinto, Y
Uchida, A
机构：
[1] Mie Univ, Sch Med, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan
[2] Osaka Hosp Railrd Employees, Dept Orthopaed Surg, Osaka, Japan
来源：
INTERNATIONAL JOURNAL OF ONCOLOGY | 1999年 / 14卷 / 06期
关键词：
chondrosarcoma; gene therapy; retrovirus vectors; suicide gene; bystander effect;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Human chondrosarcoma cells (HCS-TG) were transduced with the gene for a herpes simplex virus thymidine kinase (HSV-tk) or Escherichia coli beta-galactosidase (lacZ). We investigated the cytotoxicity of human chondrosarcoma bearing an HSV-tk gene after treatment with ganciclovir. Chondrosarcoma cells bearing an HSV-tk gene were more sensitive than non-transduced cells. Coculturing with chondrosarcoma cells bearing both an HSV-tk gene (HCS-TG-tk) and lacZ gene (HCS-TG-Z) in various ratios showed a bystander effect. Chondrosarcoma implanted in nude mice were injected with HCS-TG-tk cells. After 4 weeks, the growth of tumors was significantly prevented.
引用
收藏
页码：1137 / 1141
页数：5
相关论文
共 50 条
  • [21] Gene delivery using herpes simplex virus vectors
    Burton, EA
    Fink, DJ
    Glorioso, JC
    DNA AND CELL BIOLOGY, 2002, 21 (12) : 915 - 936
  • [22] INVITRO TRANSCRIPTION OF THE THYMIDINE KINASE GENE OF HERPES-SIMPLEX VIRUS
    READ, GS
    SUMMERS, WC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (17): : 5215 - 5219
  • [23] RETROVIRALLY TRANSMITTED GENE-THERAPY FOR GASTRIC-CARCINOMA USING HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE
    YOSHIDA, K
    KAWAMI, H
    YAMAGUCHI, Y
    KUNIYASU, H
    NISHIYAMA, M
    HIRAI, T
    YANAGIHARA, K
    TAHARA, E
    TOGE, T
    CANCER, 1995, 75 (06) : 1467 - 1471
  • [24] Combination gene therapy for hepatocellular carcinoma using herpes simplex virus thymidine kinase and interleukine-2 gene.
    Ido, A
    Uto, H
    Nakama, T
    Eto, T
    Ochiai, T
    Eori, T
    Hayashi, K
    Tsubouchi, H
    HEPATOLOGY, 1997, 26 (04) : 1596 - 1596
  • [25] Effect of gene therapy with the herpes simplex virus thymidine kinase gene on hepatic metastasis in murine colon cancer
    Hayashi, S
    Emi, N
    Yokoyama, I
    Uchida, K
    Takagi, H
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1997, 27 (01): : 40 - 43
  • [26] The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivo
    Elshami, AA
    Cook, JW
    Amin, KM
    Choi, H
    Park, JY
    Coonrod, L
    Sun, J
    MolnarKimber, K
    Wilson, JM
    Kaiser, LR
    Albelda, SM
    CANCER GENE THERAPY, 1997, 4 (04) : 213 - 221
  • [27] Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex viruus thymidine kinase ganciclovir paradigm
    Rainov, NG
    Kramm, CM
    AboodyGuterman, K
    Chase, M
    Ueki, K
    Louis, DN
    Harsh, GR
    Chiocca, A
    Breakefield, XO
    CANCER GENE THERAPY, 1996, 3 (02) : 99 - 106
  • [28] GENE-THERAPY APPLICATIONS USING HERPES-SIMPLEX VIRUS VECTORS
    GLORIOSO, JC
    DELUCA, N
    BENDER, MA
    FINK, DJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 359 - 359
  • [29] Gene delivery and gene therapy with herpes simplex virus-based vectors
    Latchman, DS
    GENE, 2001, 264 (01) : 1 - 9
  • [30] Adenoviral herpes simplex virus thymidine kinase gene therapy in an orthotopic lung cancer model
    Fukunaga, M
    Takamori, S
    Hayashi, A
    Shirouzu, K
    Kosai, K
    ANNALS OF THORACIC SURGERY, 2002, 73 (06): : 1740 - 1746
12345